T. Rowe Price Associates’s BioNTech BNTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $35.8M | Sell |
|
|||||
|
2024
Q3 | $37.9M | Buy |
|
|||||
|
2024
Q2 | $4.2M | Sell |
|
|||||
|
2024
Q1 | $4.85M | Sell |
|
|||||
|
2023
Q4 | $6.56M | Buy |
|
|||||
|
2023
Q3 | $6.58M | Hold |
|
|||||
|
2023
Q2 | $6.54M | Sell |
|
|||||
|
2023
Q1 | $7.59M | Sell |
|
|||||
|
2022
Q4 | $118M | Sell |
|
|||||
|
2022
Q3 | $169M | Sell |
|
|||||
|
2022
Q2 | $276M | Buy |
|
|||||
|
2022
Q1 | $260M | Sell |
|
|||||
|
2021
Q4 | $396M | Buy |
|
|||||
|
2021
Q3 | $318M | Sell |
|
|||||
|
2021
Q2 | $455M | Sell |
|
|||||
|
2021
Q1 | $227M | Buy |
|
|||||
|
2020
Q4 | $128M | Buy |
|
|||||
|
2020
Q3 | $82.9M | Buy |
|
|||||
|
2020
Q2 | $19.8M | Buy |
|